⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for irinotecan

Every month we try and update this database with for irinotecan cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal CancerNCT00048126
Colorectal Canc...
Irinotecan
capecitabine [X...
18 Years - Hoffmann-La Roche
A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic OriginNCT00993044
Refractory Soli...
Irinotecan
Vincristine
Temozolomide
Bevacizumab
12 Months - 20 YearsChildren's Hospital Los Angeles
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction CancerNCT02485834
Adenocarcinoma ...
Gastric Adenoca...
Gastric Cancer
FDG-PET
surgery
5-FU
capecitabine
docetaxel
Irinotecan
3D-CRT
IMRT
18 Years - Alliance for Clinical Trials in Oncology
A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid TumorsNCT06139211
Advanced Solid ...
JS015
Toripalimab
Paclitaxel
Irinotecan
Capecitabine
Oxaliplatin
Bevacizumab
Fluorouracil
Leucovorin
Gemcitabine
Albumin-Bound P...
18 Years - 75 YearsShanghai Junshi Bioscience Co., Ltd.
Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid TumorsNCT03295084
Metastatic Colo...
Irinotecan
Capecitabine
18 Years - Herlev Hospital
Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal CancerNCT00160875
Esophageal Canc...
Irinotecan hydr...
Cisplatin
18 Years - University Health Network, Toronto
Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)NCT00452634
Small Cell Lung...
Irinotecan
Cisplatin
Simvastatin
18 Years - National Cancer Center, Korea
A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal CancerNCT03522649
Previously Trea...
Napabucasin
Fluorouracil
Leucovorin
Irinotecan
18 Years - 1Globe Biomedical Co., Ltd.
Total Neoadjuvant Therapy of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer (ENSEMBLE)NCT05646511
Locally Advance...
SCRT
CAPOX
CAPOXIRI
18 Years - National Cancer Center Hospital East
Clinical and Pharmacokinetic Trial of Intra-Abdominal IrinotecanNCT00183859
Adenocarcinoma
Gastric Cancer
irinotecan
18 Years - University of Southern California
Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRCNCT03222089
Metastatic Colo...
Irinotecan
Oxaliplatin
Levoleucovorin
5-FU
GM-CSF
IL-2
18 Years - 75 YearsFujian Cancer Hospital
FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal CancerNCT02063529
Metastatic Colo...
FOLFOXIRI + Cet...
FOLFOXIRI
18 Years - 65 YearsSun Yat-sen University
Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal CancerNCT02497157
Metastatic Colo...
Oxaliplatin (L-...
Irinotecan hydr...
Continuous intr...
Levofolinate ca...
Bevacizumab (Bm...
20 Years - 70 YearsTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AINCT05381038
Solid Tumor
Gastrointestina...
Breast Cancer
QPOP
CURATE.AI
Azacitidine + d...
Azacitidine + p...
Azacitidine + i...
21 Years - 99 YearsNational University Hospital, Singapore
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)NCT01822613
Esophageal Squa...
LJM716
BYL719
Paclitaxel
Docetaxel
Irinotecan
18 Years - Novartis
A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaNCT02539537
Pancreatic Canc...
Carcinoma
Gemcitabine
Folinic Acid
5-Fluoro-uracil
Oxaliplatin
Irinotecan
L-folinic
18 Years - UNICANCER
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerNCT00642603
Colorectal Canc...
capecitabine [X...
capecitabine [X...
bevacizumab [Av...
oxaliplatin
irinotecan
18 Years - Hoffmann-La Roche
De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal CancerNCT02842580
Colorectal Neop...
5 FLUOROURACYL
acide folinique
irinotecan
Oxaliplatin
capĂŠcitabine
bevacizumab
18 Years - Federation Francophone de Cancerologie Digestive
Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel ChemotherapiesNCT04361708
Pancreatic Aden...
Gastroesophagea...
Adenocarcinoma
Oxaliplatin
Docetaxel
Leucovorin
Irinotecan
5-Fluorouracil
18 Years - University of Chicago
Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) CancersNCT00848783
Gastric Cancer
Gastric Adenoca...
Esophageal Canc...
Irinotecan
Cisplatin
Surgery
Floxuridine
Capecitabine
18 Years - NYU Langone Health
Study of Magrolimab Given Together With FOLFIRI/BEV in Patients With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)NCT05330429
Metastatic Colo...
Magrolimab
Bevacizumab
Irinotecan
Fluorouracil
Leucovorin
18 Years - Gilead Sciences
Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic MalignanciesNCT00718757
Non-Hodgkins Ly...
Hodgkin's Disea...
Acute Lymphobla...
Dexamethasone
Irinotecan
Vincristine
- 21 YearsSt. Jude Children's Research Hospital
Pharmacokinetics Study of Nimotuzumab in Patients With Solid TumorsNCT02395068
Solid Tumors
Nimotuzumab
irinotecan
18 Years - 70 YearsBiotech Pharmaceutical Co., Ltd.
Irinotecan, 5-Fluorouracil and Leucovorin With or Without Iressa in the Treatment of Metastatic Colorectal CancerNCT00233623
Metastatic Colo...
Iressa (Gefitin...
Irinotecan
5Fluorouracil
Leucovorin
18 Years - AstraZeneca
Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor MalignanciesNCT00215501
Solid Tumor
Capecitabine
5-Fluorouracil ...
Irinotecan
Cisplatin
18 Years - Dana-Farber Cancer Institute
Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic CancerNCT00871169
Pancreatic Canc...
Irinotecan, oxa...
18 Years - New Mexico Cancer Care Alliance
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)NCT06401330
Stage I Kidney ...
Stage II Kidney...
Stage III Kidne...
Stage IV Kidney...
Bone Scan
Carboplatin
Computed Tomogr...
Cyclophosphamid...
Dactinomycin
Doxorubicin
Etoposide
Irinotecan
Magnetic Resona...
Nephrectomy
Patient Observa...
Positron Emissi...
Ultrasound Imag...
Vincristine
X-Ray Imaging
- 30 YearsChildren's Oncology Group
Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic CancerNCT00042939
Pancreatic Canc...
cetuximab
docetaxel
irinotecan hydr...
18 Years - Eastern Cooperative Oncology Group
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal CancerNCT00068692
Rectal Mucinous...
Rectal Signet R...
Recurrent Recta...
Stage IIA Recta...
Stage IIB Recta...
Stage IIC Recta...
Stage IIIA Rect...
Stage IIIB Rect...
Stage IIIC Rect...
Stage IVA Recta...
Stage IVB Recta...
Radiotherapy
Fluorouracil
Leucovorin Calc...
Oxaliplatin
Irinotecan
18 Years - National Cancer Institute (NCI)
Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor MalignanciesNCT00215501
Solid Tumor
Capecitabine
5-Fluorouracil ...
Irinotecan
Cisplatin
18 Years - Dana-Farber Cancer Institute
Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract CancersNCT02720601
Biliary Tract C...
Irinotecan & Ca...
18 Years - New Mexico Cancer Care Alliance
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric CancerNCT00142350
Gastric Cancer
continuous infu...
combination of ...
oral administra...
20 Years - 75 YearsJapan Clinical Oncology Group
Cetuximab Rechallenge in Irinotecan-pretreated mCRC, KRAS, NRAS and BRAF Wild-type Treated in 1st Line With Anti-EGFR Therapy (CRICKET).NCT02296203
Metastatic Colo...
cetuximab
irinotecan
18 Years - Gruppo Oncologico del Nord-Ovest
Biomarker Development for Response Prediction by DNA Mutational AnalysisNCT01855061
Neoplasm Metast...
Biopsy
Blood samples
Pharmacokinetic...
Midazolam clear...
18 Years - UMC Utrecht
Phase I/Randomized Phase II Study of Second Line Therapy With Irinotecan + Cetuximab +/- RAD001 for Colorectal CancerNCT00522665
Colorectal Canc...
Irinotecan
Cetuximab
RAD001
18 Years - Hoosier Cancer Research Network
Metastatic Gastric Cancer FFCD 03-07NCT00374036
Stomach Cancer
Neoplasm Metast...
ECC
FOLFIRI
18 Years - University Hospital, Toulouse
Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric CancerNCT04358341
Gastric Cancer
Irinotecan
DOXOrubicin Lip...
5fluorouracil
18 Years - 70 YearsSixth Affiliated Hospital, Sun Yat-sen University
ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal CancerNCT01075048
Metastatic Colo...
Tivantinib
Placebo
Cetuximab
Irinotecan
18 Years - Daiichi Sankyo
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With CancerNCT05999994
Neoplasms
Child
Adolescent
Ramucirumab
Cyclophosphamid...
Vinorelbine
Gemcitabine
Docetaxel
Abemaciclib
Irinotecan
Temozolomide
1 Year - 39 YearsEli Lilly and Company
A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or RectumNCT01131078
Colorectal Canc...
Bevacizumab [Av...
Capecitabine
Irinotecan
18 Years - Hoffmann-La Roche
Trial in Metastatic Colorectal Cancer With FOLFIRI Plus Aflibercept as First Line TreatmentNCT02624726
Metastatic Colo...
5 Fluorouracil
Leucovorin
Irinotecan
Aflibercept
18 Years - Hellenic Oncology Research Group
Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PACNCT03665441
Pancreatic Aden...
eryaspase
Gemcitabine plu...
Irinotecan plus...
18 Years - ERYtech Pharma
Dendrobium Huoshanense Suppository in Rectal CancerNCT05079438
Locally Advance...
Dendrobium Huos...
18 Years - 75 YearsZhejiang Cancer Hospital
Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and CapecitabineNCT00072852
Breast Neoplasm...
Irinotecan
18 Years - Pfizer
NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-NaĂŻve, KRAS Mutant, Colorectal CancerNCT00856375
Colorectal Canc...
NKTR-102
irinotecan
18 Years - Nektar Therapeutics
TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal CancerNCT01060423
Colorectal Canc...
Cetuximab
Irinotecan
Irinotecan elut...
18 Years - Martin-Luther-Universität Halle-Wittenberg
Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung CancerNCT05595889
Small Cell Lung...
Angiogenesis
Chemotherapy Ef...
Surufatinib
Irinotecan
18 Years - 80 YearsFujian Cancer Hospital
Flavored, Oral Irinotecan VAL-413 (OrotecanÂŽ) Given With Temozolomide for Treatment of Recurrent Pediatric Solid TumorsNCT04337177
Solid Tumors
Neuroblastoma
Rhabdomyosarcom...
Ewing Sarcoma
Hepatoblastoma
Medulloblastoma
VAL-413
Temozolomide
1 Year - 30 YearsValent Technologies, LLC
De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal CancerNCT02842580
Colorectal Neop...
5 FLUOROURACYL
acide folinique
irinotecan
Oxaliplatin
capĂŠcitabine
bevacizumab
18 Years - Federation Francophone de Cancerologie Digestive
A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell CarcinomaNCT03430843
Esophageal Squa...
Tislelizumab
Paclitaxel
Docetaxel
Irinotecan
18 Years - BeiGene
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ PreservationNCT05610163
Locally Advance...
Stage II Rectal...
Stage III Recta...
Capecitabine
5-fluorouracil
Leucovorin calc...
Irinotecan
Oxaliplatin
Long Course Che...
Computed Tomogr...
Magnetic Resona...
Sigmoidoscopy
biopsy
18 Years - Alliance for Clinical Trials in Oncology
A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or RectumNCT02582970
Colorectal Canc...
5-Fluorouracil
Bevacizumab
Irinotecan
Oxaliplatin
18 Years - Hoffmann-La Roche
Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the PancreasNCT01560949
Pancreatic Canc...
Oxaliplatin
Irinotecan
5-FU
Gemcitabine
Radiation Thera...
18 Years - M.D. Anderson Cancer Center
Bevacizumab And Combination Chemotherapy in Rectal Cancer Until SurgeryNCT01650428
Rectal Cancer
Bevacizumab
Irinotecan
Oxaliplatin
5-Fluorouracil
18 Years - 75 YearsUniversity College, London
Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal CancerNCT00569790
Colorectal Canc...
S-1, Irinotecan...
20 Years - Taiho Pharmaceutical Co., Ltd.
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerNCT05379595
Advanced or Met...
Amivantamab
Fluorouracil
Leucovorin
Oxaliplatin
Irinotecan
18 Years - Janssen Research & Development, LLC
Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the LiverNCT02885753
Colorectal Neop...
Oxaliplatin int...
5 FU bolus
Folinic acid
Oxaliplatin int...
Panitumumab
Bevacizumab
5 FU continuous
Irinotecan
18 Years - Federation Francophone de Cancerologie Digestive
Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRCNCT03222089
Metastatic Colo...
Irinotecan
Oxaliplatin
Levoleucovorin
5-FU
GM-CSF
IL-2
18 Years - 75 YearsFujian Cancer Hospital
A Pilot Study of the Addition of Bevacizumab to VOIT Regimen for Relapsed/Refractory Pediatric Solid TumorsNCT00786669
Solid Tumor
Bevacizumab
Temozolomide
Vincristine
Irinotecan
Cefixime
1 Year - 30 YearsChildren's Hospital Medical Center, Cincinnati
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic AdenocarcinomaNCT01383538
Pancreatic Canc...
Adenocarcinoma
Pancreatic Neop...
FOLFIRINOX, IPI...
18 Years - University of California, San Francisco
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases OnlyNCT01226719
Colorectal Canc...
Panitumumab
Oxaliplatin
Irinotecan
Leucovorin
5-Fluorouracil
18 Years - SCRI Development Innovations, LLC
Phase I Trial of Adagrasib (MRTX849) in Combination With Cetuximab and Irinotecan in Patients With Colorectal CancerNCT05722327
Colon Cancer
Colorectal Canc...
MRTX849
Irinotecan
Cetuximab
18 Years - M.D. Anderson Cancer Center
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including SarcomasNCT03715933
Solid Tumors
Malignant Pleur...
Gastric Adenoca...
Colorectal Aden...
Sarcoma
Pancreatic Aden...
Ewing Sarcoma
Chondrosarcoma
GIST
SDH-deficient S...
INBRX-109
Carboplatin
Cisplatin
Pemetrexed
5-fluorouracil
Irinotecan
Temozolomide
12 Years - 85 YearsInhibrx Biosciences, Inc
Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung CancerNCT00193375
Lung Cancer
Irinotecan
Carboplatin
Bevacizumab
Radiation
18 Years - SCRI Development Innovations, LLC
A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)NCT00735436
Malignant Gliom...
Glioblastoma Mu...
Gliosarcoma
Gliadel/Avastin...
18 Years - Duke University
Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid TumorsNCT00708773
Advanced Cancer
Irinotecan
18 Years - University of Chicago
Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant GlioblastomasNCT00463073
Malignant Gliom...
Cetuximab
Bevacizumab
Irinotecan
18 Years - Rigshospitalet, Denmark
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal CancerNCT00361244
Colorectal Carc...
SU011248
Irinotecan
Cetuximab
18 Years - Massachusetts General Hospital
A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic AdenocarcinomaNCT01660711
Pancreatic Aden...
5 Fluorouracil
Leucovorin
Irinotecan
Oxaliplatin
18 Years - NorthShore University HealthSystem
Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to LiverNCT00766220
Colon Cancer
Colorectal Canc...
SIR-spheres Age...
Cetuximab
Irinotecan
18 Years - M.D. Anderson Cancer Center
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.NCT04753879
Metastatic Panc...
Nab-paclitaxel
Gemcitabine
Cisplatin
Irinotecan
Capecitabine
Pembrolizumab
Olaparib
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal CancerNCT00036517
Colorectal Neop...
Diarrhea
PHY906
18 Years - 75 YearsPhytoCeutica
The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.NCT05732129
Homologous Reco...
Fluzoparib
Irinotecan
18 Years - 75 YearsFudan University
Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer PatientsNCT03053167
ColoRectal Canc...
Irinotecan
Raltitrexed
18 Years - 75 YearsChina Medical University, China
Combination Therapy in Cancers With Mutations in DNA Repair GenesNCT05694715
Metastatic Soli...
BRCA1 Mutation
BRCA2 Mutation
ATM Gene Mutati...
PALB2 Gene Muta...
Niraparib
Irinotecan
18 Years - University of California, San Francisco
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer PatientsNCT01523431
Metastatic Colo...
Irinotecan Inje...
5-fluorouracil
Leucovorin
18 Years - The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal CancerNCT01693445
Gastrointestina...
OIS (Oxaliplati...
18 Years - Hallym University Medical Center
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and TislelizumabNCT05319639
Gastric Cancer ...
Oxaliplatin
Levo-Leucovorin
5-fluorouracil
Paclitaxel
Irinotecan
Tislelizumab
18 Years - 75 YearsFujian Cancer Hospital
Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal CancerNCT00081289
Colorectal Canc...
Radiation Thera...
Capecitabine 16...
Capecitabine 12...
Irinotecan
Oxaliplatin
Surgery
Folinic Acid
Fluorouracil
Oxaliplatin
18 Years - Radiation Therapy Oncology Group
Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRCNCT03792269
Colorectal Canc...
Chemotherapy Ef...
Chemotherapeuti...
Irinotecan
Oxaliplatin
Capecitabine
18 Years - The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: